Главная страницаLBank Stocks
Fractyl Health, Inc. Common Stock
Fractyl Health, Inc. Common Stock

Fractyl Health, Inc. Common Stock (GUTS)

24HВысокий$2.3024HНизкий$1.53
$1.55
-0.28%

Последнее обновление: 2026-10-22 10:04:41

Симуляция графика K-линий, фактические данные указаны на торговой странице

Ключевые данные

Открытие вчера
$2.14
Пред. закрытие
$1.55
Вчерашний диапазон
$1.53 - $2.30
Диапазон 52 нед.
$1.12 - $29.34
Объем торговли
6.385M
МС
$17.642M
P/E
--
EPS
$-10.56

Обзор компании

NASDAQ

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company is headquartered in Lexington, Massachusetts.

СекторHEALTHCARE
ОтрасльBIOTECHNOLOGY
Штаб-квартира3 VAN DE GRAAFF DRIVE, BURLINGTON, MA, UNITED STATES, 01803
СтранаUSA
Дата листинга2024-02-02
Конец финансового года2026-06-30
Акции в обращении13.265M
Код CIK1572616

Финансовые показатели

Индикатор2026-06-302026-03-312025-12-312025-09-30
Доход$0$0$0$0
Операционные расходы----$279K$290K
Чистая прибыль-$25.538M$9.218M-$43.727M-$45.603M
Чистая рентабельность--------
Прибыль на акцию--$0.12$-0.58$-0.71
EBITDA-$24.979M$9.499M-$43.448M-$45.313M
Эффективная налоговая ставка--------

Часто задаваемые вопросы

GUTS operates in the [specific sector and industry], focusing on [core business activity]. The company is known for its [main revenue drivers], which include [key products or services]. Investors should review the company's core strengths and market position when evaluating its stock.
GUTS primarily earns revenue through [describe main revenue drivers]. These include [specific services, manufacturing, or other operations]. The company's financial performance is largely dependent on [sector trends or market demands].
GUTS belongs to the [specific sector and industry]. This sector is characterized by [major trends, challenges, or growth potential]. Investors should be aware of how GUTS competes within this industry and how macroeconomic factors might impact its performance.
Yes, GUTS pays dividends to its shareholders, reflecting its commitment to returning value. The dividend rate and yield depend on the company’s financial health and market conditions. Investors should monitor dividend announcements for updates on payouts.
Investing in GUTS involves risks such as [specific risks tied to the company or sector, e.g., economic sensitivity, regulatory challenges]. While the company has growth potential, external factors like [mention risks like competition or market volatility] can impact its stock performance.
GUTS competes with companies like [name major relevant competitors]. These competitors operate in the same industry and may impact GUTS’s market share. Investors often compare financial metrics and strategic positioning within this competitive landscape.
GUTS’s valuation metrics, such as price-to-earnings (P/E) ratio and price-to-book (P/B) ratio, should be compared to peers in its industry. Differences in valuation often reflect growth prospects, risks, or unique operational characteristics of the business.
Opportunities for GUTS include [specific growth factors, such as market expansion, product innovations, or strategic partnerships]. However, investors should also consider potential risks, such as [industry challenges or operational hurdles] that might impact its ability to capitalize on these opportunities.
Предупреждение о рисках
  1. 1.Цены на акции могут сильно колебаться, инвестируйте осторожно. Прошлые результаты не гарантируют будущую доходность.
  2. 2.Торговля цифровыми активами сопряжена с рыночными, техническими и иными рисками. Пожалуйста, принимайте взвешенные решения и рационально распределяйте активы.
  3. 3.Информация на этой странице предназначена только для ознакомления и не является инвестиционной рекомендацией.